|
1
|
Keeley EC, Boura JA and Grines CL: Primary
angioplasty versus intravenous thrombolytic therapy for acute
myocardial infarction: a quantitative review of 23 randomised
trials. Lancet. 361:13–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: a delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kersten JR, Schmeling TJ, Pagel PS, Gross
GJ and Warltier DC: Isoflurane mimics ischemic preconditioning via
activation of K(ATP) channels: reduction of myocardial infarct size
with an acute memory phase. Anesthesiology. 87:361–370. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cason BA, Gamperl AK, Slocum RE and Hickey
RF: Anesthetic-induced preconditioning: previous administration of
isoflurane decreases myocardial infarct size in rabbits.
Anesthesiology. 87:1182–1190. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsutsumi YM, Patel HH, Lai NC, Takahashi
T, Head BP and Roth DM: Isoflurane produces sustained cardiac
protection after ischemia-reperfusion injury in mice.
Anesthesiology. 104:495–502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toller WG, Kersten JR, Pagel PS, Hettrick
DA and Warltier DC: Sevoflurane reduces myocardial infarct size and
decreases the time threshold for ischemic preconditioning in dogs.
Anesthesiology. 91:1437–1446. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Penta de Peppo A, Polisca P, Tomai F, et
al: Recovery of LV contractility in man is enhanced by preischemic
administration of enflurane. Ann Thorac Surg. 68:112–118. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Hert SG, ten Broecke PW, Mertens E, et
al: Sevoflurane but not propofol preserves myocardial function in
coronary surgery patients. Anesthesiology. 97:42–49. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pravdic D, Mio Y, Sedlic F, et al:
Isoflurane protects cardiomyocytes and mitochondria by immediate
and cytosol-independent action at reperfusion. Br J Pharmacol.
160:220–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Novalija E, Kevin LG, Camara AK, Bosnjak
ZJ, Kampine JP and Stowe DF: Reactive oxygen species precede the
epsilon isoform of protein kinase C in the anesthetic
preconditioning signaling cascade. Anesthesiology. 99:421–428.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uecker M, Da Silva R, Grampp T, Pasch T,
Schaub MC and Zaugg M: Translocation of protein kinase C isoforms
to subcellular targets in ischemic and anesthetic preconditioning.
Anesthesiology. 99:138–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tanaka K, Weihrauch D, Kehl F, et al:
Mechanism of preconditioning by isoflurane in rabbits: a direct
role for reactive oxygen species. Anesthesiology. 97:1485–1490.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Müllenheim J, Ebel D, Frässdorf J, Preckel
B, Thämer V and Schlack W: Isoflurane preconditions myocardium
against infarction via release of free radicals. Anesthesiology.
96:934–940. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pain T, Yang XM, Critz SD, et al: Opening
of mitochondrial K(ATP) channels triggers the preconditioned state
by generating free radicals. Circ Res. 87:460–466. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kersten JR, Schmeling TJ, Hettrick DA,
Pagel PS, Gross GJ and Warltier DC: Mechanism of myocardial
protection by isoflurane. Role of adenosine triphosphate-regulated
potassium (KATP) channels. Anesthesiology. 85:794–807; discussion
727A. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dana A, Skarli M, Papakrivopoulou J and
Yellon DM: Adenosine A(1) receptor induced delayed preconditioning
in rabbits: induction of p38 mitogen-activated protein kinase
activation and Hsp27 phosphorylation via a tyrosine kinase- and
protein kinase C-dependent mechanism. Circ Res. 86:989–997. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mitchell MB, Meng X, Ao L, Brown JM,
Harken AH and Banerjee A: Preconditioning of isolated rat heart is
mediated by protein kinase C. Circ Res. 76:73–81. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fryer RM, Wang Y, Hsu AK and Gross GJ:
Essential activation of PKC-delta in opioid-initiated
cardioprotection. Am J Physiol Heart Circ Physiol. 280:H1346–H1353.
2001.PubMed/NCBI
|
|
19
|
Ping P, Takano H, Zhang J, et al:
Isoform-selective activation of protein kinase C by nitric oxide in
the heart of conscious rabbits: a signaling mechanism for both
nitric oxide-induced and ischemia-induced preconditioning. Circ
Res. 84:587–604. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cope DK, Impastato WK, Cohen MV and Downey
JM: Volatile anesthetics protect the ischemic rabbit myocardium
from infarction. Anesthesiology. 86:699–709. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toller WG, Montgomery MW, Pagel PS,
Hettrick DA, Warltier DC and Kersten JR: Isoflurane-enhanced
recovery of canine stunned myocardium: role for protein kinase C?
Anesthesiology. 91:713–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Churchill EN and Mochly-Rosen D: The roles
of PKCdelta and epsilon isoenzymes in the regulation of myocardial
ischaemia/reperfusion injury. Biochem Soc Trans. 35:1040–1042.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong L and Su JY: Isoflurane activates
PKC and Ca2+-calmodulin-dependent protein kinase II via
MAP kinase signaling in cultured vascular smooth muscle cells.
Anesthesiology. 96:148–154. 2002. View Article : Google Scholar
|
|
24
|
Ono Y, Fujii T, Ogita K, Kikkawa U,
Igarashi K and Nishizuka Y: The structure, expression, and
properties of additional members of the protein kinase C family. J
Biol Chem. 263:6927–6932. 1988.PubMed/NCBI
|
|
25
|
Kukan M: Emerging roles of proteasomes in
ischemia-reperfusion injury of organs. J Physiol Pharmacol.
55:3–15. 2004.PubMed/NCBI
|
|
26
|
Raphael J, Rivo J and Gozal Y:
Isoflurane-induced myocardial preconditioning is dependent on
phosphatidylinositol-3-kinase/Akt signalling. Br J Anaesth.
95:756–763. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen CH, Budas GR, Churchill EN, Disatnik
MH, Hurley TD and Mochly-Rosen D: Activation of aldehyde
dehydrogenase-2 reduces ischemic damage to the heart. Science.
321:1493–1495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mio Y, Bienengraeber MW, Marinovic J, et
al: Age-related attenuation of isoflurane preconditioning in human
atrial cardiomyocytes: roles for mitochondrial respiration and
sarcolemmal adenosine triphosphate-sensitive potassium channel
activity. Anesthesiology. 108:612–620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ljubkovic M, Mio Y, Marinovic J, et al:
Isoflurane preconditioning uncouples mitochondria and protects
against hypoxia-reoxygenation. Am J Physiol Cell Physiol.
292:C1583–C1590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu ZY and Liu J: Mechanism of cardiac
preconditioning with volatile anaesthetics. Anaesth Intensive Care.
37:532–538. 2009.PubMed/NCBI
|
|
31
|
Suzuki K, Murtuza B, Smolenski RT, et al:
Overexpression of interleukin-1 receptor antagonist provides
cardioprotection against ischemia-reperfusion injury associated
with reduction in apoptosis. Circulation. 104:I308–I313. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fliss H and Gattinger D: Apoptosis in
ischemic and reperfused rat myocardium. Circ Res. 79:949–956. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gottlieb RA, Burleson KO, Kloner RA,
Babior BM and Engler RL: Reperfusion injury induces apoptosis in
rabbit cardiomyocytes. J Clin Invest. 94:1621–1628. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meldrum DR, Dinarello CA, Shames BD, et
al: Ischemic preconditioning decreases postischemic myocardial
tumor necrosis factor-alpha production. Potential ultimate effector
mechanism of preconditioning. Circulation. 98:II214–II219.
1998.PubMed/NCBI
|
|
35
|
Lang XE, Wang X, Zhang KR, Lv JY, Jin JH
and Li QS: Isoflurane preconditioning confers cardioprotection by
activation of ALDH2. PLoS One. 8:e524692013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li SY, Li Q, Shen JJ, et al: Attenuation
of acetaldehyde-induced cell injury by overexpression of aldehyde
dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role
of MAP kinase signaling. J Mol Cell Cardiol. 40:283–294. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Endo J, Sano M, Katayama T, et al:
Metabolic remodeling induced by mitochondrial aldehyde stress
stimulates tolerance to oxidative stress in the heart. Circ Res.
105:1118–1127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zheng H, Liu J, Liu C, et al:
Calcium-sensing receptor activating phosphorylation of PKCδ
translocation on mitochondria to induce cardiomyocyte apoptosis
during ischemia/reperfusion. Mol Cell Biochem. 358:335–343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hunter JC, Kostyak JC, Novotny JL, Simpson
AM and Korzick DH: Estrogen deficiency decreases ischemic tolerance
in the aged rat heart: Roles of PKCdelta, PKCepsilon, Akt, and
GSK3beta. Am J Physiol Regul Integr Comp Physiol. 292:R800–R809.
2007. View Article : Google Scholar
|
|
40
|
Majumder PK, Mishra NC, Sun X, et al:
Targeting of protein kinase C delta to mitochondria in the
oxidative stress response. Cell Growth Differ. 12:465–470.
2001.PubMed/NCBI
|
|
41
|
Kajimoto T, Ohmori S, Shirai Y, Sakai N
and Saito N: Subtype-specific translocation of the delta subtype of
protein kinase C and its activation by tyrosine phosphorylation
induced by ceramide in HeLa cells. Mol Cell Biol. 21:1769–1783.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Blass M, Kronfeld I, Kazimirsky G,
Blumberg PM and Brodie C: Tyrosine phosphorylation of protein
kinase Cdelta is essential for its apoptotic effect in response to
etoposide. Mol Cell Biol. 22:182–195. 2002. View Article : Google Scholar
|
|
43
|
Emoto Y, Kisaki H, Manome Y, Kharbanda S
and Kufe D: Activation of protein kinase Cdelta in human myeloid
leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
Blood. 87:1990–1996. 1996.PubMed/NCBI
|
|
44
|
Emoto Y, Manome Y, Meinhardt G, et al:
Proteolytic activation of protein kinase C delta by an ICE-like
protease in apoptotic cells. EMBO J. 14:6148–6156. 1995.PubMed/NCBI
|
|
45
|
Ghayur T, Hugunin M, Talanian RV, et al:
Proteolytic activation of protein kinase C delta by an ICE/CED
3-like protease induces characteristics of apoptosis. J Exp Med.
184:2399–2404. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leverrier S, Vallentin A and Joubert D:
Positive feedback of protein kinase C proteolytic activation during
apoptosis. Biochem J. 368:905–913. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Basu A and Akkaraju GR: Regulation of
caspase activation and cis-diamminedichloroplatinum(II)-induced
cell death by protein kinase C. Biochemistry. 38:4245–4251. 1999.
View Article : Google Scholar : PubMed/NCBI
|
